Ustekinumab is an effective and safe therapy in anti-TNF refractory Crohn's Disease: a two year real-life observational study from Spain
No Thumbnail Available
Identifiers
Date
2021-05-01
Authors
Rueda Sanchez, J.
Cabello Ramirez, N.
Camara Baena, S.
Keco Huerga, A.
de la Borbolla Serres, J. Garcia
Castro Fernandez, M.
Grande Santamaria, L.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford univ press
Metrics
Export
